Paul W. Doetsch is Deputy Scientific Director of NIEHS and
head of the Mutagenesis and DNA Repair Regulation Group. He received a B.S. in
biochemistry from the University of Maryland, an M.S. in medicinal chemistry
and pharmacognosy from Purdue University, and a Ph.D. in biochemistry from
Temple University. Following postdoctoral training at the Dana Farber Cancer
Institute and Harvard Medical School, he served on the faculty of Emory
University School of Medicine for 32 years, led a DNA repair and mutagenesis
research group, and held various leadership positions, including Associate
Director for Basic Research (2005–2017) of the Winship Cancer Institute. He
joined NIEHS in January 2018. The Mutagenesis and DNA Repair Regulation Group’s
major areas of research include the regulation of DNA repair and the
interaction between the replication and transcription machinery and DNA damage.
The group’s DNA repair studies are primarily focused on the base excision
repair (BER) pathway, including its genetic and biological consequences, such
as tumorigenesis and dysregulation, as well as interactions between BER
components and other repair systems.
Paul W. Doetsch is Deputy Scientific Director of NIEHS and
head of the Mutagenesis and DNA Repair Regulation Group. He received a B.S. in
biochemistry from the University of Maryland, an M.S. in medicinal chemistry
and pharmacognosy from Purdue University, and a Ph.D. in biochemistry from
Temple University. Following postdoctoral training at the Dana Farber Cancer
Institute and Harvard Medical School, he served on the faculty of Emory
University School of Medicine for 32 years, led a DNA repair and mutagenesis
research group, and held various leadership positions, including Associate
Director for Basic Research (2005–2017) of the Winship Cancer Institute. He
joined NIEHS in January 2018. The Mutagenesis and DNA Repair Regulation Group’s
major areas of research include the regulation of DNA repair and the
interaction between the replication and transcription machinery and DNA damage.
The group’s DNA repair studies are primarily focused on the base excision
repair (BER) pathway, including its genetic and biological consequences, such
as tumorigenesis and dysregulation, as well as interactions between BER
components and other repair systems.